Free Access
Editorial
Issue
Med Sci (Paris)
Volume 39, Number 3, Mars 2023
Néphrologie pédiatrique : de grandes avancées et un futur rempli d’espoir
Page(s) 203 - 204
Section Editorial
DOI https://doi.org/10.1051/medsci/2023054
Published online 21 March 2023
  1. Global Tuberculosis Report 2022. World Health Organization. https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2022. [Google Scholar]
  2. Nyang’wa BT, Berry C, Kazounis E, et al. A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis. N Engl J Med 2022; 387 : 2331–43. [CrossRef] [PubMed] [Google Scholar]
  3. Paton NI, Cousins C, Suresh C, et al. Treatment Strategy for Rifampin-Susceptible Tuberculosis. N Engl J Med 2023; NEJMoa2212537. [Google Scholar]
  4. Liu Q, Zhu J, Dulberger CL, et al. Tuberculosis treatment failure associated with evolution of antibiotic resilience. Science 2022; 378 : 1111–8. [CrossRef] [PubMed] [Google Scholar]
  5. Gygli SM, Loiseau C, Jugheli L, et al. Prisons as ecological drivers of fitness-compensated multidrug-resistant Mycobacterium tuberculosis. Nat Med 2021; 27 : 1171–7. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.